Ángel Cabrera/president.gatech.edu;David Ku/LinkedIn
Jun 26, 2026, 13:25
Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
Ángel Cabrera, President at Georgia Institute of Technology, shared a post on LinkedIn:
“It affects 1/3 of the human population and can be severe enough to lead to hospitalization.
Yet its causes remain a mystery, it’s rarely discussed in public, often goes undiagnosed, and it remains a consistently underfunded and understudied area of science.
My colleague David Ku and his team are changing that by studying how clotting disorders contribute to heavy menstrual bleeding.”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian